By: Rees Hakeem Oduro
The recent news release by the Narcotics Control Commission (NACOC) on Wednesday, 11 February 2026, announcing the commencement of licensing for medicinal and industrial cannabis cultivation, has generated widespread public debate across the country. While public scrutiny is healthy in any policy shift, much of the current discussion has been driven by misunderstanding, fear, and misinformation. It is therefore important to place the directive in its proper legal and public health context so that citizens can appreciate both its limits and its safeguards.
First and foremost, Ghana has not legalised recreational cannabis. Under the Narcotics Control Commission Act, 2020 (Act 1019), and the Cultivation and Management of Cannabis Regulations, 2023 (L.I. 2475), licensing is strictly limited to medicinal, industrial, and research purposes. Only cannabis varieties containing not more than 0.3% tetrahydrocannabinol (THC) are permitted. Recreational use remains illegal, and the possession, trafficking, sale, or cultivation of cannabis above the 0.3% THC threshold continues to constitute a criminal offence. Importantly, even the approved low‑THC variety is illegal without a valid NACOC licence.
The idea that the policy will lead to more people abusing cannabis for recreational purposes is one of the most prevalent public concerns. Although this concern is reasonable, the regulatory structure in place has been specifically designed to minimise diversion. Licensing is restricted to qualified entities that must meet stringent requirements, including robust security protocols, comprehensive product traceability systems, and strict quality assurance standards. NACOC also retains full inspection and enforcement powers. International experience reveals that low-THC industrial hemp programmes do not always translate into increased recreational use when such controls are applied appropriately.
The question of whether Ghana has adequate monitoring capacity has also been raised, and this is a valid policy question. However, it’s crucial to remember that the existing structure requires multi-agency collaboration amongst relevant national institutions and designates the Cannabis Regulation Department at NACOC as the primary supervision authority. Licences are not granted automatically; they are conditional and may be withdrawn if regulatory conditions are not met. Facilities are continuously monitored for compliance. Therefore, rather than being an open commercial market, the regime is set up as a strictly regulated system.
Some observers have also cautioned that increased availability could worsen the already existing substance use challenges, especially given the limited availability of treatment and rehabilitation services in parts of the country. This concern highlights an important truth: Ghana and NACOC must invest in drug prevention and continue to expand treatment and recovery services regardless of this policy. The Commission must establish the Substance Use Disorder Rehabilitation Fund as stipulated by Section 22 of the Act 1019. However, it is equally important to understand that the permitted cannabis strain, capped at 0.3% THC, has minimal psychoactive effects and is primarily intended for medical products, industrial hemp materials, and scientific research. It is not the high‑THC cannabis typically associated with abuse.
Additionally, the policy is also driven by strategic national interests. Industrial hemp offers economic opportunities for the manufacturing of paper, textiles, cosmetics, pharmaceuticals, and innovative agriculture. The industry can increase export revenue, bring in investment, and create jobs if it is properly regulated. Furthermore, local pharmaceutical development will be strengthened, and research into cannabis-based medicinal products will be supported by controlled cultivation. Law enforcement authorities can better focus on high-THC illicit marketplaces by using a controlled framework to differentiate between authorised and criminal businesses.
Thus, it is critical to separate myths from facts. Ghana has not legalised marijuana for recreational use. The cultivation is not available to everyone but only to those who meet the legitimate licensing requirements. The streets are not being opened to uncontrolled marijuana distribution. What has been introduced is a tightly regulated, licence‑based system for specific low‑THC (0.3%) cannabis cultivars under strict state supervision.
For the directive to achieve its intended objectives, three core tenets are essential and must remain strong: consistent regulatory enforcement by NACOC, sustained public education and prevention efforts, and deliberate expansion of treatment and rehabilitation services. Encouragingly, the current framework acknowledges the significance of these elements, but the ongoing development and public awareness campaigns will remain crucial.
To sum up, the new licence directive is not a complete legalisation of cannabis in Ghana but rather a careful and legally binding policy initiative. When interpreted correctly in the context of Act 1019 and L.I. 2475, many of the prevailing concerns lack a factual basis. Ultimately, transparent implementation, strict enforcement, and ongoing funding for public health solutions will determine the policy’s success. Under proper supervision, Ghana can appropriately explore the legal, medicinal and industrial prospects of cannabis while preserving public safety.
Rees Hakeem Oduro (reeskofi@gmail.com)
Silver Spring, Pedu
Cape Coast
Disclaimer
The views expressed are solely those of the author and do not reflect the official position of any state agency, organisation, institution or media house with which the author may be affiliated.
